HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CIR Panel: Epidemiology Evidence Still Lacking Regarding Possible Hair Dye-Cancer Links

Executive Summary

Potential connections between hair-dye use and cancer incidence have been just hazily sketched in epidemiological studies to date, signaling a need for more targeted, better-designed investigations, CIR’s Expert Panel says. The group finalized a related resource document at its December meeting in Washington after multiple rounds of revisions and outside expert input.    

You may also be interested in...



NIH Study Links Hair Dyes, Straighteners To Breast Cancer Risk; Causation Piece Remains Lacking

Analyzing data from around 47,000 women enrolled in its Sister Study, the National Institute of Environmental Health Sciences found that regular users of permanent hair dye were 9% more likely to develop breast cancer compared with less frequent users. The increased probability reached 60% for African American women who dye their hair every five to eight weeks. Industry and NGO EWG respond.

CIR Expert Panel Seeks Proper Balance In Respiratory Exposure Doc, Says Particle Size Isn’t All-Important

The Cosmetic Ingredient Review’s efforts to finalize an Aerosols resource document show the program’s public interchange at work. At its Dec. 3-4 meeting, the CIR Expert Panel was divided on whether the document properly characterizes the importance of particle size in assessing the inhalation risks of ingredients in aerosol cosmetics, a point raised by NGO Women’s Voices for the Earth.

Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking

The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS139934

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel